Electra Therapeutics (ETRA) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 6, 2026

Net buying: insiders sold $0 and bought $7.2M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$7.2M net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ETRA filings

Are insiders buying or selling Electra Therapeutics, Inc. Common stock (ETRA) stock?

Net buying: insiders sold $0 and bought $7.2M of ETRA stock on the open market in the 90 days to Nov 6, 2026, according to SEC Form 4 filings. The largest was Gordon, Carl L (Director), who bought $3.6M. The latest filing was on Nov 5, 2026.

Which members of Congress have traded ETRA recently?

None. No member of Congress disclosed a ETRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETRA smart-money data?

This summary uses filings available on Nov 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on ETRA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Carl L Gordon, bought $3.6M, open market, filed Nov 5
- Orbimed Advisors LLC, bought $3.6M, open market, filed Nov 5
Lean long · thin2 buys · $7.2M
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ETRA filings

Are insiders buying or selling Electra Therapeutics, Inc. Common stock (ETRA) stock?

Which members of Congress have traded ETRA recently?

None. No member of Congress disclosed a ETRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETRA smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Bought$7.2M

Buys (3)

GC
Gordon Carl L
Dir, 10% · Cluster · Nov 5
$3.6M
bought
Signals like this: n=540, 52% finished lower at D15, median -0.9% vs SPY +0.4%
OA
Orbimed Advisors Llc
Dir, 10% · Cluster · Nov 5
$3.6M
bought
GC
Gordon Carl L
Dir, 10% · Sep 23
$20.0M
private deal

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Other smart money signals

Activist stakes, short interest & more

1 item

F1
Filing 13d GModerate
Westlake BioPartners Fund I, L.P. filed SC 13G on Electra Therapeutics, Inc. (passive 10.1% stake)

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

No earnings history.

Next report

What the street expects next

Open: $7.95
High: $7.99
Low: $6.96
Prev close: $7.97
52-wk high: $15.50
52-wk low: $6.87
Mkt cap: $500.3M
ROE: +0.0%
Profit margin: +0.0%
Op margin: +0.0%

FY 2024 to FY 2025

What it sold, what it cost, what was left.

RevenueProfit

FY 2024FY 2025

Income statement, 2 periods, all values in US dollars
USD	FY 2024	FY 2025
What came in
RevenueTotal revenue	$0	$0
What it spent
Research and development	$19.3M	$50.4M
Sales and adminSelling, general and administrative	$7.0M	$11.5M
Total operating expenses	$26.3M	$61.9M
What was left
Operating profitOperating income	-$26.3M	-$61.9M
Interest on debtInterest expense	$0	$1.4M
Profit before tax	-$24.8M	-$62.0M
Net profitNet income	-$24.8M	-$62.0M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$24.8M	-$60.5M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

36balanced

20D volatility

85%annualized

52-week range

$7.16

$6.87$15.50

20D support

$6.87recent floor

20D resistance

$9.80recent ceiling

Returns

5D -17.1%20D -21.7%

Price vs moving averages

SMA20 -16.2%

12 macro signals shaping ETRA right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Smart money at a glance

Filings to Nov 6, 2026

Net buying: insiders sold $0 and bought $7.2M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$7.2M net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ETRA filings

Are insiders buying or selling Electra Therapeutics, Inc. Common stock (ETRA) stock?

Which members of Congress have traded ETRA recently?

None. No member of Congress disclosed a ETRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETRA smart-money data?

Smart money on ETRA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Carl L Gordon, bought $3.6M, open market, filed Nov 5
- Orbimed Advisors LLC, bought $3.6M, open market, filed Nov 5
Lean long · thin2 buys · $7.2M
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ETRA filings

Are insiders buying or selling Electra Therapeutics, Inc. Common stock (ETRA) stock?

Which members of Congress have traded ETRA recently?

None. No member of Congress disclosed a ETRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETRA smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Bought$7.2M

Buys (3)

GC
Gordon Carl L
Dir, 10% · Cluster · Nov 5
$3.6M
bought
Signals like this: n=540, 52% finished lower at D15, median -0.9% vs SPY +0.4%
OA
Orbimed Advisors Llc
Dir, 10% · Cluster · Nov 5
$3.6M
bought
GC
Gordon Carl L
Dir, 10% · Sep 23
$20.0M
private deal

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Other smart money signals

Activist stakes, short interest & more

1 item

F1
Filing 13d GModerate
Westlake BioPartners Fund I, L.P. filed SC 13G on Electra Therapeutics, Inc. (passive 10.1% stake)

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

No earnings history.

Next report

What the street expects next

Open: $7.95
High: $7.99
Low: $6.96
Prev close: $7.97
52-wk high: $15.50
52-wk low: $6.87
Mkt cap: $500.3M
ROE: +0.0%
Profit margin: +0.0%
Op margin: +0.0%

FY 2024 to FY 2025

What it sold, what it cost, what was left.

RevenueProfit

FY 2024FY 2025

Income statement, 2 periods, all values in US dollars
USD	FY 2024	FY 2025
What came in
RevenueTotal revenue	$0	$0
What it spent
Research and development	$19.3M	$50.4M
Sales and adminSelling, general and administrative	$7.0M	$11.5M
Total operating expenses	$26.3M	$61.9M
What was left
Operating profitOperating income	-$26.3M	-$61.9M
Interest on debtInterest expense	$0	$1.4M
Profit before tax	-$24.8M	-$62.0M
Net profitNet income	-$24.8M	-$62.0M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$24.8M	-$60.5M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

36balanced

20D volatility

85%annualized

52-week range

$7.16

$6.87$15.50

20D support

$6.87recent floor

20D resistance

$9.80recent ceiling

Returns

5D -17.1%20D -21.7%

Price vs moving averages

SMA20 -16.2%

12 macro signals shaping ETRA right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Electra Therapeutics, Inc. Common stock

Smart money at a glance

What do analysts expect?

Questions about ETRA filings

Smart money on ETRA

Questions about ETRA filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Results versus expectations

What the street expects next

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Electra Therapeutics, Inc. Common stock

Smart money at a glance

What do analysts expect?

Questions about ETRA filings

Smart money on ETRA

Questions about ETRA filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Results versus expectations

What the street expects next

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Electra Therapeutics, Inc. Common stock

Overview

Questions about ETRA filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

Electra Therapeutics, Inc. Common stock

Overview

Questions about ETRA filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.